Innoviz director reports initial 723,734-share stake

Innoviz Technologies Ltd. director Amichai Steimberg reported his initial holdings on a Form 3.

Rhea-AI Filing Summary

Innoviz Technologies Ltd. director Amichai Steimberg reported his initial holdings on a Form 3. He directly holds 723,734 ordinary shares, including 321,250 shares issuable from restricted share units granted on May 13, 2025. These RSUs vest on April 5, 2026, with no exercise price.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Steimberg Amichai

Role Director

Type	Security	Shares	Price	Value
holding	Ordinary Shares	--	--	--

Holdings After Transaction: Ordinary Shares — 723,734 shares (Direct)

Footnotes (1)

1. F1. Includes 321,250 ordinary shares issuable upon vesting of restricted share units (RSUs) granted on May 13, 2025. The RSUs vest on April 5, 2026. Each RSU represents a contingent right to receive one ordinary share. No exercise price is applicable.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many Innoviz Technologies (INVZ) shares does Amichai Steimberg report on Form 3?

Amichai Steimberg reports beneficial ownership of 723,734 ordinary shares of Innoviz Technologies Ltd. This total includes both currently held shares and shares that may be issued upon vesting of restricted share units disclosed in the filing.

What portion of Amichai Steimberg’s Innoviz (INVZ) holdings are restricted share units?

The filing states that 321,250 ordinary shares are issuable upon vesting of restricted share units (RSUs). These RSUs represent a substantial part of Steimberg’s reported 723,734-share position and will convert into ordinary shares if vesting conditions are met.

When do Amichai Steimberg’s Innoviz (INVZ) RSUs vest?

The restricted share units reported by Amichai Steimberg vest on April 5, 2026. After vesting, each RSU entitles him to receive one ordinary share of Innoviz Technologies Ltd., subject to the other terms of the grant described in the award documentation.

Does Amichai Steimberg need to pay an exercise price for his Innoviz (INVZ) RSUs?

No, the filing specifies that no exercise price is applicable to the restricted share units. Each RSU represents a contingent right to receive one ordinary share of Innoviz Technologies Ltd. once vesting occurs, without any additional cash payment required.

When were Amichai Steimberg’s Innoviz (INVZ) restricted share units granted?

The Form 3 notes that Amichai Steimberg’s restricted share units were granted on May 13, 2025. These RSUs, totaling 321,250 units, are scheduled to vest on April 5, 2026, at which point they convert into ordinary shares on a one-for-one basis.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/18/2026 - 06:21 PM Learn about SEC filing dates

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Steimberg Amichai

(Last) (First) (Middle)

C/O INNOVIZ TECHNOLOGIES LTD.

5 URI ARIAV STREET, BUILDING C

(Street)

ROSH HA'AIN 4809202

(City) (State) (Zip)

UNITED STATES

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
03/18/2026

3. Issuer Name and Ticker or Trading Symbol
Innoviz Technologies Ltd. [ INVZ ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Ordinary Shares	723,734(1)	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Includes 321,250 ordinary shares issuable upon vesting of restricted share units (RSUs) granted on May 13, 2025. The RSUs vest on April 5, 2026. Each RSU represents a contingent right to receive one ordinary share. No exercise price is applicable.

Remarks:

[Exhibit 24 - Power of Attorney.]

	/s/ Dafna Raz - Attorney-in-Fact	03/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)